The potential role of orm2 in the development of colorectal cancer

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Zhang, Xuhua ^a,b   Xiao, Zhiying ^b   Liu, Xiaoyong ^c   Du, Lutao ^a   Wang, Lili ^a   Wang, Shun ^a   Zheng, Ni ^a   Zheng, Guixi ^a   Li, Wei ^a   Zhang, Xin ^a   Dong, Zhaogang ^a   Zhuang, Xuewei ^a   Wang, Chuanxin ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; APOLIPOPROTEIN C3; COMPLEMENT COMPONENT C4D; GLUTAMATE DEHYDROGENASE (NADP); MEMBRANE PROTEIN; OROSOMUCOID; PROTEIN ORM2; RETINOL BINDING PROTEIN; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; ORM2 PROTEIN, HUMAN; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PROGNOSIS; CARCINOGENESIS; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; UPREGULATION; WESTERN BLOTTING; BLOOD; CELL TRANSFORMATION; COLORECTAL TUMOR; INTESTINE MUCOSA; MASS SPECTROMETRY; METABOLISM; PATHOLOGY;

AGED; BLOTTING, WESTERN; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INTESTINAL MUCOSA; MALE; MASS SPECTROMETRY; NEOPLASM PROTEINS; OROSOMUCOID; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84857381391     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031868     Document Type: Article

References (40)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics. CA Cancer J Clin 59: 225-249.
2. Park IJ, Choi GS, Lim KH, Kang BM, Jun SH, (2009) Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level. Ann Surg Oncol 16: 3087-3093.
3. Wichmann MW, Lau-Werner U, Muller C, Hornung HM, Stieber P, et al. (2000) Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer. Anticancer Res 20: 4953-4955.
4. Zeng Z, Cohen AM, Urmacher C, (1993) Usefulness of carcinoembryonic antigen monitoring despite normal preoperative values in node-positive colon cancer patients. Dis Colon Rectum 36: 1063-1068.
5. Mariani G, Carmellini M, Bonaguidi F, Benelli MA, Toni MG, (1980) Serum CEA monitoring in the follow-up of colorectal cancer patients with negative preoperative serum CEA. Eur J Cancer 16: 1099-1103.
6. Wulfkuhle JD, Liotta LA, Petricoin EF, (2003) Proteomic applications for the early detection of cancer. Nat Rev Cancer 3: 267-275.
7. Nagalla SR, Canick JA, Jacob T, Schneider KA, Reddy AP, et al. (2007) Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers. J Proteome Res 6: 1245-1257.
8. Kolialexi A, Mavrou A, Spyrou G, Tsangaris GT, (2008) Mass spectrometry-based proteomics in reproductive medicine. Mass Spectrom Rev 27: 624-634.
9. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, et al. (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3: 1154-1169.
10. Kim YS, Son OL, Lee JY, Kim SH, Oh S, et al. (2008) Lectin precipitation using phytohemagglutinin-L(4) coupled to avidin-agarose for serological biomarker discovery in colorectal cancer. Proteomics 8: 3229-3235.
11. Ma Y, Peng J, Huang L, Liu W, Zhang P, et al. (2009) Searching for serum tumor markers for colorectal cancer using a 2-D DIGE approach. Electrophoresis 30: 2591-2599.
12. Ward DG, Suggett N, Cheng Y, Wei W, Johnson H, et al. (2006) Identification of serum biomarkers for colon cancer by proteomic analysis. Br J Cancer 94: 1898-1905.
13. Kim HJ, Kang HJ, Lee H, Lee ST, Yu MH, et al. (2009) Identification of S100A8 and S100A9 as serological markers for colorectal cancer. J Proteome Res 8: 1368-1379.
14. Zheng GX, Wang CX, Qu X, Deng XM, Deng BP, et al. (2006) Establishment of serum protein pattern for screening colorectal cancer using SELDI-TOF-MS. Exp Oncol 28: 282-287.
15. Sorensson J, Matejka GL, Ohlson M, Haraldsson B, (1999) Human endothelial cells produce orosomucoid, an important component of the capillary barrier. Am J Physiol 276: H530-534.
16. Kjeldsen J, Lauritsen K, De Muckadell OB, (1997) Serum concentrations of orosomucoid: improved decision-making for tapering prednisolone therapy in patients with active inflammatory bowel disease? Scand J Gastroenterol 32: 933-941.
17. Irmak S, Tilki D, Heukeshoven J, Oliveira-Ferrer L, Friedrich M, et al. (2005) Stage-dependent increase of orosomucoid and zinc-alpha2-glycoprotein in urinary bladder cancer. Proteomics 5: 4296-4304.
18. Briese V, Szabo DG, Than GN, Willroth PO, Straube W, (1986) Levels of tumor markers (orosomucoid, pregnancy-associated alpha 2-glycoprotein, pregnancy protein-1, placental specific-tissue protein 10, placental specific-tissue protein 12, alpha 1-fetoprotein) in the serum of patients with bronchial carcinoma. Arch Geschwulstforsch 56: 13-22.
19. Arnold JN, Saldova R, Abd Hamid U, Rudd PM, (2007) Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomics 8: 3284-3293.
20. Rudd PM, Bland M, Dwek RA, Axford JS, (1999) Sugar printing rheumatic diseases: a potential method for disease differentiation using immunoglobulin G oligosaccharides. Arthritis Rheum 42: 1682-1690.
21. Ercan A, Cui J, Chatterton D, Deane K, Hazen M, et al. (2010) IgG galactosylation aberrancy precedes disease onset, correlates with disease activity and is prevalent in autoantibodies in rheumatoid arthritis. Arthritis Rheum 62: 2239-2248.
22. Abd Hamid UM, Royle L, Saldova R, Radcliffe CM, Harvey DJ, et al. (2008) A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression. Glycobiology 18: 1105-1118.
23. Saldova R, Royle L, Radcliffe CM, Hamid UM, Evans R, et al. (2007) Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology 17: 1344-1356.
24. Pedersen JW, Blixt O, Bennett EP, Tarp MA, Dar I, et al. (2010) Seromic profiling of colorectal cancer patients with novel glycopeptide microarray. Int J Cancer 8: 1860-1871.
25. Moore A, Medarova Z, Potthast A, Dai G P, (2004) In vivo targeting of underglycosylated MUC-1 tumor antigen using a multimodal imaging probe. Cancer Res 64: 1821-1827.
26. Tumani H, Pfeifle M, Lehmensiek V, Rau D, Mogel H, et al. (2009) Candidate biomarkers of chronic inflammatory demyelinating polyneuropathy (CIDP): proteome analysis of cerebrospinal fluid. J Neuroimmunol 214: 109-112.
27. Ochi Y, (1983) Studies on immunological characteristic of CEA-CEA may be a biosynthetic precursor of alpha 1-acid glycoprotein. Gan To Kagaku Ryoho 10: 585-594.
28. Nagahara A, Nakayama M, Oka D, Tsuchiya M, Kawashima A, et al. SERPINE2 is a possible candidate promotor for lymph node metastasis in testicular cancer. Biochem Biophys Res Commun 391: 1641-1646.
29. de Sa SV, Correa-Giannella ML, Machado MC, Krogh K, de Almeida MQ, et al. (2007) Serpin peptidase inhibitor clade A member 1 as a potential marker for malignancy in insulinomas. Clin Cancer Res 13: 5322-5330.
30. Han YP, Yan C, Garner WL, (2008) Proteolytic activation of matrix metalloproteinase-9 in skin wound healing is inhibited by alpha-1-antichymotrypsin. J Invest Dermatol 128: 2334-2342.
31. Braghin E, Galimberti D, Scarpini E, Bresolin N, Baron P, (2009) Alpha1-antichymotrypsin induces TNF-alpha production and NF-kappaB activation in the murine N9 microglial cell line. Neurosci Lett 467: 40-42.
32. Hutchinson S, Luo LY, Yousef GM, Soosaipillai A, Diamandis EP, (2003) Purification of human kallikrein 6 from biological fluids and identification of its complex with alpha(1)-antichymotrypsin. Clin Chem 49: 746-751.
33. Bai Y, Shakeley RM, Attardi G, (2000) Tight control of respiration by NADH dehydrogenase ND5 subunit gene expression in mouse mitochondria. Mol Cell Biol 20: 805-815.
34. Cardol P, Boutaffala L, Memmi S, Devreese B, Matagne RF, et al. (2008) In Chlamydomonas, the loss of ND5 subunit prevents the assembly of whole mitochondrial complex I and leads to the formation of a low abundant 700 kDa subcomplex. Biochim Biophys Acta 1777: 388-396.
35. Corral M, Paris B, Baffet G, Tichonicky L, Guguen-Guillouzo C, et al. (1989) Increased level of the mitochondrial ND5 transcript in chemically induced rat hepatomas. Exp Cell Res 184: 158-166.
36. Zhadanov SI, Grechanina EY, Grechanina YB, Gusar VA, Fedoseeva NP, et al. (2007) Fatal manifestation of a de novo ND5 mutation: Insights into the pathogenetic mechanisms of mtDNA ND5 gene defects. Mitochondrion 7: 260-266.
37. Sui G, Zhou S, Wang J, Canto M, Lee EE, et al. (2006) Mitochondrial DNA mutations in preneoplastic lesions of the gastrointestinal tract: a biomarker for the early detection of cancer. Mol Cancer 5: 73.
38. Patz EF Jr, Campa MJ, Gottlin EB, Kusmartseva I, Guan XR, et al. (2007) Panel of serum biomarkers for the diagnosis of lung cancer. J Clin Oncol 25: 5578-5583.
39. Putzki H, Reichert B, Hinz M, (1990) Retinol-binding protein, haptoglobin and ceruloplasmin-tumor markers in colorectal cancer? Z Gesamte Inn Med 45: 50-52.
40. Rai AJ, Gelfand CA, Haywood BC, Warunek DJ, Yi J, et al. (2005) HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 5: 3262-3277.